Biosante Pharmaceuticals Inc - Amended Securities Registration (section 12(b)) (8-A12B/A)
October 31 2007 - 5:21PM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
__________________
FORM
8-A/A
FOR
REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR
12(g)
OF THE SECURITIES EXCHANGE ACT OF 1934
__________________
BIOSANTE
PHARMACEUTICALS, INC.
(Exact
Name of registrant as specified in its charter)
Delaware
|
58-2301143
|
|
(State
of incorporation or organization)
|
(I.R.S.
Employer Identification Number)
|
|
111
Barclay Boulevard
Lincolnshire,
Illinois
|
60069
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Securities
to be registered pursuant to Section 12(b) of the Act:
Title
of each class
to
be so registered
|
Name
of each exchange on which
each
class is to be registered
|
Common
Stock, par value $0.0001
|
The
NASDAQ Stock Market LLC
|
If
this
form relates to the registration of a class of securities pursuant to Section
12(b) of the Exchange Act and is effective pursuant to General Instruction
A.(c), check the following
box:
x
If
this
form relates to the registration of a class of securities pursuant to Section
12(g) of the Exchange Act and is effective pursuant to General Instruction
A.(d), check the following
box:
o
Securities
Act registration statement file number to which this form
relates:
Not applicable
Securities
to be registered pursuant to Section 12(g) of the
Act:
None
Item
1. Description of Registrant’s Securities to Be
Registered
The
description of the registrant’s common stock, par value $0.0001 per share, is
incorporated by reference to the material under the section “Description of
Capital Stock” in the registrant's registration statement on Form SB-2 as filed
with the Securities and Exchange Commission on September 5, 2003, as amended,
Commission Reg. No. 333-108550.
Item
2. Exhibits.
|
|
3.1
|
Amended
and Restated Certificate of Incorporation of BioSante Pharmaceuticals,
Inc.
|
3.2
|
Amendment
to Amended and Restated Certificate of Incorporation of BioSante
Pharmaceuticals, Inc.
|
3.3
|
Bylaws
of BioSante Pharmaceuticals, Inc.
|
|
|
SIGNATURE
Pursuant
to the requirements of Section 12 of the Securities Exchange Act of 1934, the
registrant has duly caused this registration statement to be signed on its
behalf by the undersigned, thereunto duly authorized.
BIOSANTE
PHARMACEUTICALS, INC.
By:
/s/Phillip
B. Donenberg
Phillip
B.
Donenberg
Chief
Financial Officer, Treasurer and Secretary
Dated: October
31, 2007
BIOSANTE
PHARMACEUTICALS, INC.
REGISTRATION
STATEMENT ON FORM 8-A/A
INDEX
TO EXHIBITS
|
|
|
3.1
|
Amended
and Restated Certificate of Incorporation of BioSante Pharmaceuticals,
Inc.
|
Incorporated
by reference to Exhibit 3.1 contained in BioSante’s Registration Statement
on Form SB-2
(Reg.
No. 333-64218)
|
3.2
|
Amendment
to Amended and Restated Certificate of Incorporation of BioSante
Pharmaceuticals, Inc.
|
Incorporated
by reference to Exhibit 3.2 contained in BioSante’s Form 8-A
(File
No. 001-31812)
|
3.3
|
Bylaws
of BioSante Pharmaceuticals, Inc.
|
Incorporated
by reference to Exhibit 3.2 contained in BioSante’s Registration Statement
on Form SB-2
(Reg.
No. 333-64218)
|
Biosante Pharma (AMEX:BPA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Biosante Pharma (AMEX:BPA)
Historical Stock Chart
From Jul 2023 to Jul 2024